glp 1 antagonist drugs glp-1_analogs [TUSOM The GLP-1 Agonists and Obesity:

They just dont want it anymore

Maintain close ophthalmic follow-up for pre-existing proliferative retinopathy

doi: 10.1055/s-2007-1003745 173 ThondamSKDaousiCWildingJPHolstJJAmeenGIYangCet al

GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction

Implications from the study included that 8.9% of diabetic patients and 6.7% of obese patients on GLP-1 developed NAION compared to 1.8% and 0.8% respectively in those using other medications

Over time, this leads to: Chronically elevated blood glucose Increased fat storage (especially abdominal fat) Persistent hunger and cravings Energy crashes Naturopathic interventions focus on stabilizing blood glucose through whole-food nutrition rich in fiber, protein, and healthy fats